| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT |
| ADMINISTRATION | ORAL |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 082000 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER CONTENT QUANTITY | 4.000 TABLETS |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CHLOROQUINE PHOSPHATE TABLETS USP 500 MG BT 4 TABS |
| TOTAL PRIMARY CONTAINER QUANTITY | 1 |
| SPECIAL FEATURES | USED FOR PROPHYLAXIS AND TREATMENT OF ACUTE ATTACKS OF MALARIA CAUSED BY PLASMODIUM VIVAX, P MALARIAE, P OVALE AND SUSCEPTIBLE STRAINS OF P FALCIPARUM; EXTRAINTESTINAL AMEBIASIS; WITH CHILD PROOF CAP; NSN WAS CREATED TO PERMIT INVENTORY MANAGEMENT OF THE REPACKAGED DOSAGE FORM. PACKAGE OF 4 PREPARED BY REPACKAGING THE BULK PRODUCT. THE NSN IS NOT PROCURABLE, DO NOT REQUISITION |